Identification of Differentially Expressed Transcripts and Pathways in Blood One Week and Six Months Following Implant of Left Ventricular Assist Devices

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Mitchell, Adam ^a   Guan, Weihua ^b   Staggs, Rodney ^a   Hamel, Aimee ^b   Hozayen, Sameh ^a   Adhikari, Neeta ^a   Grindle, Suzanne ^a   Desir, Snider ^a   John, Ranjit ^a   Hall, Jennifer L ^a   Eckman, Peter ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; CELL SURVIVAL; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; HEART FAILURE; HEART VENTRICLE REMODELING; HUMAN; IMPLANTATION; LYMPHOCYTE ACTIVATION; MALE; POSTOPERATIVE PERIOD; RNA EXTRACTION; RNA SEQUENCE; T LYMPHOCYTE;

AGED; BIOLOGICAL MARKERS; BLOTTING, WESTERN; FEMALE; GENE EXPRESSION PROFILING; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 84886914517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077951     Document Type: Article

References (52)

1. Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, et al. (2011) Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 57: 1890-1898. doi:10.1016/S0735-1097(11)61890-1. PubMed: 21545946.
2. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, et al. (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345: 1435-1443. doi:10.1056/NEJMoa012175. PubMed: 11794191.
3. Hellawell JL, Margulies KB, (2012) Myocardial reverse remodeling. Cardiovasc Ther 30: 172-181. doi:10.1111/j.1755-5922.2010.00247.x. PubMed: 21108773.
4. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, et al. (2007) Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357: 885-896. doi:10.1056/NEJMoa067758. PubMed: 17761592.
5. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, et al. (2009) Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361: 2241-2251. doi:10.1056/NEJMoa0909938. PubMed: 19920051.
6. Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, et al. (2012) Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation. Circulation 125: 3191-3200. doi:10.1161/CIRCULATIONAHA.111.058412. PubMed: 22619284.
7. Eckman PM, John R, (2012) Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation 125: 3038-3047. doi:10.1161/CIRCULATIONAHA.111.040246. PubMed: 22711669.
8. Hall JL, Grindle S, Han X, Fermin D, Park S, et al. (2004) Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics 17: 283-291. doi:10.1152/physiolgenomics.00004.2004. PubMed: 14872006.
9. Chen Y, Park S, Li Y, Missov E, Hou M, et al. (2003) Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol Genomics 14: 251-260. PubMed: 12824457.
10. Hall JL, Birks EJ, Grindle S, Cullen ME, Barton PJ, et al. (2007) Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 28: 613-627. PubMed: 17132651.
11. Blaxall BC, Tschannen-Moran BM, Milano CA, Koch WJ, (2003) Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol 41: 1096-1106. doi:10.1016/S0735-1097(03)00043-3. PubMed: 12679207.
12. Razeghi P, Young ME, Ying J, Depre C, Uray IP, et al. (2002) Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology 97: 203-209. doi:10.1159/000063122. PubMed: 12145475.
13. Razeghi P, Mukhopadhyay M, Myers TJ, Williams JN, Moravec CS, et al. (2001) Myocardial tumor necrosis factor-alpha expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support. Ann Thorac Surg 72: 2044-2050. doi:10.1016/S0003-4975(01)03172-1. PubMed: 11789791.
14. Margulies KB, Matiwala S, Cornejo C, Olsen H, Craven WA, et al. (2005) Mixed messages: transcription patterns in failing and recovering human myocardium. Circ Res 96: 592-599. doi:10.1161/01.RES.0000159390.03503.c3. PubMed: 15718504.
15. Sinha A, Shahzad K, Latif F, Cadeiras M, Von Bayern MP, et al. (2010) Peripheral blood mononuclear cell transcriptome profiles suggest T-cell immunosuppression after uncomplicated mechanical circulatory support device surgery. Hum Immunol 71: 164-169. doi:10.1016/j.humimm.2009.10.012. PubMed: 19879911.
16. Wang Z, Gerstein M, Snyder M, (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10: 57-63. doi:10.1038/nrg2484. PubMed: 19015660.
17. Martin JA, Wang Z, (2011) Next-generation transcriptome assembly. Nat Rev Genet 12: 671-682. doi:10.1038/nrg3068. PubMed: 21897427.
18. Trapnell C, Pachter L, Salzberg SL, (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111. doi:10.1093/bioinformatics/btp120. PubMed: 19289445.
19. Roberts A, Trapnell C, Donaghey J, Rinn JL, Pachter L, (2011) Improving RNA-Seq expression estimates by correcting for fragment bias. Genome Biol 12: R22. doi:10.1186/gb-2011-12-s1-p22. PubMed: 21410973.
20. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511-515. doi:10.1038/nbt.1621. PubMed: 20436464.
21. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc B Stat Methodol) 57: 289-300.
22. Fermin DR, Barac A, Lee S, Polster SP, Hannenhalli S, et al. (2008) Sex and age dimorphism of myocardial gene expression in nonischemic human heart failure. Circ Cardiovasc Genet 1: 117-125. doi:10.1161/CIRCGENETICS.108.802652. PubMed: 20031553.
23. Vrtovec B, Radovancevic R, Delgado RM, Radovancevic B, Bracey AW, et al. (2009) Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support. Eur J Heart Fail 11: 1000-1004. doi:10.1093/eurjhf/hfp110. PubMed: 19789404.
24. Mankad AK, Tang DG, Clark WB, Flattery M, Harton S, et al. (2012) Persistent anemia after implantation of the total artificial heart. J Card Fail 18: 433-438. doi:10.1016/j.cardfail.2012.03.003. PubMed: 22633300.
25. Turbpaiboon C, Wilairat P, (2010) Alpha-hemoglobin stabilizing protein: molecular function and clinical correlation. Front Biosci 15: 1-11. doi:10.2741/3601. PubMed: 20036801.
26. Wohlschlaeger J, Levkau B, Takeda A, Takeda N, Stypmann J, et al. (2012) Increase of ABCG2/BCRP+ side population stem cells in myocardium after ventricular unloading. J Heart Lung Transplant 31: 318-324. doi:10.1016/j.healun.2011.11.015. PubMed: 22243701.
27. Martin CM, Ferdous A, Gallardo T, Humphries C, Sadek H, et al. (2008) Hypoxia-inducible factor-2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells. Circ Res 102: 1075-1081. doi:10.1161/CIRCRESAHA.107.161729. PubMed: 18356544.
28. Sly WS, Hu PY, (1995) Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 64: 375-401. doi:10.1146/annurev.bi.64.070195.002111. PubMed: 7574487.
29. Dorn GW 2nd, (2011) Nix Nought Nothing: fairy tale or real deal. J Mol Cell Cardiol 51: 497-500. doi:10.1016/j.yjmcc.2010.09.011. PubMed: 20858501.
30. Chen Y, Lewis W, Diwan A, Cheng EH, Matkovich SJ, et al. (2010) Dual autonomous mitochondrial cell death pathways are activated by Nix/BNip3L and induce cardiomyopathy. Proc Natl Acad Sci U S A 107: 9035-9042. doi:10.1073/pnas.0914013107. PubMed: 20418503.
31. Dorn GW 2nd, Kirshenbaum LA, (2008) Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3L. Oncogene 27 (Suppl 1):: S158-S167. doi:10.1038/sj.onc.1210903. PubMed: 19641501.
32. Diwan A, Wansapura J, Syed FM, Matkovich SJ, Lorenz JN, et al. (2008) Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation. Circulation 117: 396-404. doi:10.1161/CIRCULATIONAHA.107.727073. PubMed: 18178777.
33. Yussman MG, Toyokawa T, Odley A, Lynch RA, Wu G, et al. (2002) Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 8: 725-730. PubMed: 12053174.
34. Yoshioka J, Chutkow WA, Lee S, Kim JB, Yan J, et al. (2012) Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury. J Clin Invest 122: 267-279. doi:10.1172/JCI44927. PubMed: 22201682.
35. Lin Z, Kumar A Sen, Banerjee S, Staniszewski K, Parmar K, et al. (2005) Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 96: e48-e57. doi:10.1161/01.RES.0000159707.05637.a1. PubMed: 15718498. doi:10.1161/01.RES.0000159707.05637.a1 PubMed: 15718498.
36. Schleicher M, Brundin F, Gross S, Müller-Esterl W, Oess S, (2005) Cell cycle-regulated inactivation of endothelial NO synthase through NOSIP-dependent targeting to the cytoskeleton. Mol Cell Biol 25: 8251-8258. doi:10.1128/MCB.25.18.8251-8258.2005. PubMed: 16135813.
37. Vanburen P, Ma J, Chao S, Mueller E, Schneider DJ, et al. (2011) Blood gene expression signatures associate with heart failure outcomes. Physiol Genomics 43: 392-397. doi:10.1152/physiolgenomics.00175.2010. PubMed: 21266504.
38. Harris TJ, Waltman TJ, Carter SM, Maisel AS, (1995) Effect of prolonged catecholamine infusion on immunoregulatory function: implications in congestive heart failure. J Am Coll Cardiol 26: 102-109. doi:10.1016/0735-1097(95)00123-H. PubMed: 7797738.
39. Maisel AS, (1994) Beneficial effects of metoprolol treatment in congestive heart failure. Reversal of sympathetic-induced alterations of immunologic function. Circulation 90: 1774-1780. doi:10.1161/01.CIR.90.4.1774. PubMed: 7923661.
40. Ankersmit HJ, Edwards NM, Schuster M, John R, Kocher A, et al. (1999) Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Circulation 100: II211-II215. PubMed: 10567306.
41. Ankersmit HJ, Tugulea S, Spanier T, Weinberg AD, Artrip JH, et al. (1999) Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 354: 550-555. doi:10.1016/S0140-6736(98)10359-8. PubMed: 10470699.
42. Kimball PM, Flattery M, McDougan F, Kasirajan V, (2008) Cellular immunity impaired among patients on left ventricular assist device for 6 months. Ann Thorac Surg 85: 1656-1661. doi:10.1016/j.athoracsur.2008.01.050. PubMed: 18442560.
43. Kimball P, Flattery M, Kasirajan V, (2006) T-cell response to staphylococcal enterotoxin B is reduced among heart failure patients on ventricular device support. Transplant Proc 38: 3695-3696. doi:10.1016/j.transproceed.2006.10.153. PubMed: 17175370.
44. Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Miyazaki M, (2010) Immunosuppression following surgical and traumatic injury. Surg Today 40: 793-808. doi:10.1007/s00595-010-4323-z. PubMed: 20740341.
45. Tang TT, Ding YJ, Liao YH, Yu X, Xiao H, et al. (2010) Defective circulating CD4CD25+Foxp3+CD127(low) regulatory T-cells in patients with chronic heart failure. Cell Physiol Biochem 25: 451-458. doi:10.1159/000303050. PubMed: 20332626.
46. Torre-Amione G, Stetson SJ, Youker KA, Durand JB, Radovancevic B, et al. (1999) Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: A potential mechanism for cardiac recovery. Circulation 100: 1189-1193. doi:10.1161/01.CIR.100.11.1189. PubMed: 10484539.
47. Clark AL, Loebe M, Potapov EV, Egerer K, Knosalla C, et al. (2001) Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight. Eur Heart J 22: 2275-2283. doi:10.1053/euhj.2001.2693. PubMed: 11728148.
48. Bartling B, Milting H, Schumann H, Darmer D, Arusoglu L, et al. (1999) Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation 100: II216-II223. PubMed: 10567307.
49. Kihm AJ, Kong Y, Hong W, Russell JE, Rouda S, et al. (2002) An abundant erythroid protein that stabilizes free alpha-haemoglobin. Nature 417: 758-763. doi:10.1038/nature00803. PubMed: 12066189.
50. Yu X, Kong Y, Dore LC, Abdulmalik O, Katein AM, et al. (2007) An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis. J Clin Invest 117: 1856-1865. doi:10.1172/JCI31664. PubMed: 17607360.
51. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, et al. (2011) Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation 123: e18-e209. doi:10.1161/CIR.0b013e3182009701. PubMed: 21160056.
52. Lou X, Templeton DL, John R, Dengel DR, (2012) Effects of continuous flow left ventricular assist device support on microvascular endothelial function. J Cardiovasc Transl Res 5: 345-350 PubMed: 21932132.